Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1α-mediated invasion of breast carcinoma cells

Amalraj Thangasamy, Jessica Rogge, Sudhakar Ammanamanchi

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Hypoxia-inducible factor-1α (HIF-1α) overexpression was shown to be associated with invasion and metastasis of tumors and tumor cell line a. The identification of molecular targets that contribute to HIF-1α-mediated invasion is under intensive investigation. We iave analyzed the role of recepteur d'origine nantais (RON), a tyrosine kinase receptor for macrophage-stimulating protein (MSP) that plays a role in breast cancer cell invasion as one of the molecular targets of HIF-1α. Analysis of a panel of breast cain cer cell lines indicated a correlation between HIF-1α and RON ression. Treatment of HIF-1α- and RON- positive breastcaner cells with HIF-1α inhibitor, echinomycin, led to the inhibition of HIF-1α activity and RON expression. We have identified HIF-1α binding site on the RON promoter. Chromatin immunoprecipitation analysis and site-directed mutagenesis of the RON promoter confirmed the binding of HIF-1α to RON promoter. HIF-1α inhibitor-, echinomycin-, or short hairpin RNA-mediated selective knockdown of HIF-1α or HIF-1α target RON tyrosine kinase abrogated RON gene expression, and the RON ligand macrophage-stimulating protein mediated invasion of breast cancer cells. Consequently, the data presented herein demonstrated RON as a novel molecular target of HIF-1α and suggest a potential therapeutic role for HIF-1α or RON tyrosine kinase inhibitors in the blockade of RON tyrosine kinase-mediated invasion of carcinoma cells.

Original languageEnglish (US)
Pages (from-to)14001-14010
Number of pages10
JournalJournal of Biological Chemistry
Volume284
Issue number21
DOIs
StatePublished - May 22 2009

Fingerprint

Hypoxia-Inducible Factor 1
Protein-Tyrosine Kinases
Cells
Breast Neoplasms
Echinomycin
RON protein
Tumors
Cell Hypoxia
Mutagenesis
Chromatin Immunoprecipitation
Receptor Protein-Tyrosine Kinases
Site-Directed Mutagenesis
Tumor Cell Line
Gene expression
Small Interfering RNA

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1α-mediated invasion of breast carcinoma cells. / Thangasamy, Amalraj; Rogge, Jessica; Ammanamanchi, Sudhakar.

In: Journal of Biological Chemistry, Vol. 284, No. 21, 22.05.2009, p. 14001-14010.

Research output: Contribution to journalArticle

Thangasamy, Amalraj ; Rogge, Jessica ; Ammanamanchi, Sudhakar. / Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1α-mediated invasion of breast carcinoma cells. In: Journal of Biological Chemistry. 2009 ; Vol. 284, No. 21. pp. 14001-14010.
@article{ad23794d294d44ac966cac21dfc2f481,
title = "Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1α-mediated invasion of breast carcinoma cells",
abstract = "Hypoxia-inducible factor-1α (HIF-1α) overexpression was shown to be associated with invasion and metastasis of tumors and tumor cell line a. The identification of molecular targets that contribute to HIF-1α-mediated invasion is under intensive investigation. We iave analyzed the role of recepteur d'origine nantais (RON), a tyrosine kinase receptor for macrophage-stimulating protein (MSP) that plays a role in breast cancer cell invasion as one of the molecular targets of HIF-1α. Analysis of a panel of breast cain cer cell lines indicated a correlation between HIF-1α and RON ression. Treatment of HIF-1α- and RON- positive breastcaner cells with HIF-1α inhibitor, echinomycin, led to the inhibition of HIF-1α activity and RON expression. We have identified HIF-1α binding site on the RON promoter. Chromatin immunoprecipitation analysis and site-directed mutagenesis of the RON promoter confirmed the binding of HIF-1α to RON promoter. HIF-1α inhibitor-, echinomycin-, or short hairpin RNA-mediated selective knockdown of HIF-1α or HIF-1α target RON tyrosine kinase abrogated RON gene expression, and the RON ligand macrophage-stimulating protein mediated invasion of breast cancer cells. Consequently, the data presented herein demonstrated RON as a novel molecular target of HIF-1α and suggest a potential therapeutic role for HIF-1α or RON tyrosine kinase inhibitors in the blockade of RON tyrosine kinase-mediated invasion of carcinoma cells.",
author = "Amalraj Thangasamy and Jessica Rogge and Sudhakar Ammanamanchi",
year = "2009",
month = "5",
day = "22",
doi = "10.1074/jbc.M809320200",
language = "English (US)",
volume = "284",
pages = "14001--14010",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "21",

}

TY - JOUR

T1 - Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1α-mediated invasion of breast carcinoma cells

AU - Thangasamy, Amalraj

AU - Rogge, Jessica

AU - Ammanamanchi, Sudhakar

PY - 2009/5/22

Y1 - 2009/5/22

N2 - Hypoxia-inducible factor-1α (HIF-1α) overexpression was shown to be associated with invasion and metastasis of tumors and tumor cell line a. The identification of molecular targets that contribute to HIF-1α-mediated invasion is under intensive investigation. We iave analyzed the role of recepteur d'origine nantais (RON), a tyrosine kinase receptor for macrophage-stimulating protein (MSP) that plays a role in breast cancer cell invasion as one of the molecular targets of HIF-1α. Analysis of a panel of breast cain cer cell lines indicated a correlation between HIF-1α and RON ression. Treatment of HIF-1α- and RON- positive breastcaner cells with HIF-1α inhibitor, echinomycin, led to the inhibition of HIF-1α activity and RON expression. We have identified HIF-1α binding site on the RON promoter. Chromatin immunoprecipitation analysis and site-directed mutagenesis of the RON promoter confirmed the binding of HIF-1α to RON promoter. HIF-1α inhibitor-, echinomycin-, or short hairpin RNA-mediated selective knockdown of HIF-1α or HIF-1α target RON tyrosine kinase abrogated RON gene expression, and the RON ligand macrophage-stimulating protein mediated invasion of breast cancer cells. Consequently, the data presented herein demonstrated RON as a novel molecular target of HIF-1α and suggest a potential therapeutic role for HIF-1α or RON tyrosine kinase inhibitors in the blockade of RON tyrosine kinase-mediated invasion of carcinoma cells.

AB - Hypoxia-inducible factor-1α (HIF-1α) overexpression was shown to be associated with invasion and metastasis of tumors and tumor cell line a. The identification of molecular targets that contribute to HIF-1α-mediated invasion is under intensive investigation. We iave analyzed the role of recepteur d'origine nantais (RON), a tyrosine kinase receptor for macrophage-stimulating protein (MSP) that plays a role in breast cancer cell invasion as one of the molecular targets of HIF-1α. Analysis of a panel of breast cain cer cell lines indicated a correlation between HIF-1α and RON ression. Treatment of HIF-1α- and RON- positive breastcaner cells with HIF-1α inhibitor, echinomycin, led to the inhibition of HIF-1α activity and RON expression. We have identified HIF-1α binding site on the RON promoter. Chromatin immunoprecipitation analysis and site-directed mutagenesis of the RON promoter confirmed the binding of HIF-1α to RON promoter. HIF-1α inhibitor-, echinomycin-, or short hairpin RNA-mediated selective knockdown of HIF-1α or HIF-1α target RON tyrosine kinase abrogated RON gene expression, and the RON ligand macrophage-stimulating protein mediated invasion of breast cancer cells. Consequently, the data presented herein demonstrated RON as a novel molecular target of HIF-1α and suggest a potential therapeutic role for HIF-1α or RON tyrosine kinase inhibitors in the blockade of RON tyrosine kinase-mediated invasion of carcinoma cells.

UR - http://www.scopus.com/inward/record.url?scp=67649774148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649774148&partnerID=8YFLogxK

U2 - 10.1074/jbc.M809320200

DO - 10.1074/jbc.M809320200

M3 - Article

VL - 284

SP - 14001

EP - 14010

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 21

ER -